Bemelman Frederike, Yong Si-La, Tissingh Rudi, Schellekens Peter, ten Berge Ineke
Academic Medical Center, University of Amsterdam, The Netherlands.
Transpl Int. 2005 Apr;18(4):423-8. doi: 10.1111/j.1432-2277.2004.00056.x.
'Active suppression', a mechanism of transplantation tolerance, can spread to newly introduced minor antigens once these antigens are linked to tolerizing antigens. We explored whether this suppression can extend to major histocompatibility (MHC) antigens and whether this phenomenon can be demonstrated once tolerance is induced to a MHC antigen. Mice were tolerized using donor bone marrow plus CD4 and CD8 monoclonal antibodies. The following strain combinations were used: AKR (H-2k) into CBA (H-2k), a multiple minor difference and B6 (H-2b) into B6(bm12) (H-2b), a MHC class II difference. Tolerance was tested by a donorskingraft. CBA mice tolerant to AKR received a second skin carrying either AKR antigens plus additional multiple minor antigens [F1(AKRxBalb.K)] or carrying additional minors and a MHC class I antigen (B10.AKM-H2M). B6(bm12) (H-2b) tolerant to B6 (H-2b) were grafted with skin from a Balb.B donor (Balb minors linked to the tolerizing class II antigen) or from a B10.A(3R) strain (a MHC class I antigen linked to the tolerizing class II antigen). CBA mice tolerant to AKR accepted F1(AKRxBalb.K) skin, whereas F1(CBAxBalb.K) were rejected. Rejection of B10.AKM/H2M skin by tolerant mice was delayed as compared with nontolerant mice. Tolerant and nontolerant B6(bm12) mice rejected Balb.B skin and B10.A(3R) skin within the same time. Thus, in this model, suppression was linked to minors. Alloreactivity against minors and majors could be suppressed. Suppression linked to a class II antigen could not be demonstrated.
“主动抑制”是移植耐受的一种机制,一旦这些新引入的次要抗原与耐受诱导抗原相连接,这种机制就能扩散至这些次要抗原。我们探究了这种抑制是否能扩展至主要组织相容性(MHC)抗原,以及一旦诱导出对MHC抗原的耐受,这种现象是否能够得到证实。使用供体骨髓加CD4和CD8单克隆抗体诱导小鼠产生耐受。采用了以下品系组合:将AKR(H-2k)小鼠的骨髓移植到CBA(H-2k)小鼠体内,这是一个多基因次要差异组合;以及将B6(H-2b)小鼠的骨髓移植到B6(bm12)(H-2b)小鼠体内,这是一个MHC II类差异组合。通过供体皮肤移植来检测耐受情况。对AKR产生耐受的CBA小鼠接受了携带AKR抗原加额外多个次要抗原[F1(AKR×Balb.K)]或携带额外次要抗原和一个MHC I类抗原(B10.AKM-H2M)的第二块皮肤。对B6(H-2b)产生耐受的B6(bm12)(H-2b)小鼠被移植了来自Balb.B供体的皮肤(与耐受诱导II类抗原相连的Balb次要抗原)或来自B10.A(3R)品系的皮肤(与耐受诱导II类抗原相连的一个MHC I类抗原)。对AKR产生耐受的CBA小鼠接受了F1(AKR×Balb.K)皮肤,而F1(CBA×Balb.K)皮肤则被排斥。与未耐受小鼠相比,耐受小鼠对B10.AKM/H2M皮肤的排斥反应有所延迟。耐受和未耐受的B6(bm12)小鼠在相同时间内排斥了Balb.B皮肤和B10.A(3R)皮肤。因此,在这个模型中,抑制与次要抗原相关。针对次要抗原和主要抗原的同种异体反应性均可被抑制。与II类抗原相关的抑制未能得到证实。